BioCentury
ARTICLE | Company News

Apovia, Corixa deal

August 25, 2003 7:00 AM UTC

Under a co-development deal, CRXA granted Apovia commercial rights to its RC-529 synthetic adjuvant for use in an undisclosed therapeutic vaccine. Apovia develops vaccines to prevent and treat infect...